In the era of personalized cancer treatment, large-scale genetic analysis of tumors is considered to be key for a better selection of patients for an appropriate anticancer therapy. Owing to this ...

ESMO's recommendation is therefore that large panels of genes can be used if they generate an acceptable increase in the overall cost, drugs included. Considering that the results of NGS panels could ...

All the patients analyzed in this study have been seen in the context of a genetic session and fulfilled at least one the following criteria: (i) breast cancer before the age of 36, (ii) medullary ...

Assessment of PARP1 mRNA expression as prognostic of aggressive pathology and adverse outcomes, and as predictor of response to PARP inhibition in castration-sensitive prostate cancer. Association of ...

The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostic professionals, today released cost analysis results and health economic ...

AUSTIN, Texas--(BUSINESS WIRE)--Asuragen, Inc., a molecular diagnostics company delivering easy-to-use products for complex testing in genetics and oncology, today announced publication of a study ...

Next-generation sequencing (NGS) of samples from the sputum of intubated patients, as outlined in their recently published paper in the Journal of Clinical Microbiology, may enable more focused ...

NGS Opens a Range of Possibilities for the Analysis of Diverse DNA and RNA Populations The advent of next-generation sequencing (NGS), also referred to as massively parallel or deep sequencing, ...

Lugano, Switzerland, 25 August 2020 - Recommendations on the use of next-generation sequencing (NGS) for patients with metastatic cancers are being launched today [25 August] by the European Society ...

The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostic professionals, today released cost analysis results and health economic ...